Company intelligence / Profile preview

TheraNova

San Francisco, California, United Statestheranova.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

TheraNova has spun out over 20 companies since inception. Portfolio companies have raised more than $400M. Achieved at least 12 FDA regulatory clearances/approvals (PMA/510K). Over 120 US patents filed/granted. More than 30 clinical trials conducted/concluded.

Therapeutic areas: OtherCardiovascular
Modalities: Device (including medical devices and diagnostics)
Industry: Investors

Partnerships

Collaborations with reimbursement consultantsClinical research partners in US, Europe, South AmericaInvestors include government grants and angel fundingWest Coast Consortium for Technology & Innovation in Pediatrics

Beyond the preview

Go deeper on TheraNova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraNova.

Explore the full profile